Cancer and globalization{star, open}

Biomedicine and Pharmacotherapy

Volumn 62, Issue 2, 2008, Pages 110-121

  Sasco, Annie J ^a  

^a INSERM   (France)

Author keywords

Cancer incidence; Environment; Globalization

Indexed keywords

ACADEMIC ACHIEVEMENT; ARTICLE; CANCER PREVENTION; CANCER RESEARCH; CAREER; COMPUTER PROGRAM; CONSUMER; ENVIRONMENTAL EXPOSURE; GLOBAL CHANGE; GOVERNMENT; HUMAN; IARC MONOGRAPH PROGRAM; INTERNATIONAL COOPERATION; LIFESTYLE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; ANIMAL; COMMERCIAL PHENOMENA; DIET; HEALTH; NEOPLASM; POLLUTANT; REVIEW; RISK FACTOR;

CARCINOGEN; DRUG;

ANIMALS; CARCINOGENS; COMMERCE; DIET; ENVIRONMENTAL POLLUTANTS; HUMANS; NEOPLASMS; PHARMACEUTICAL PREPARATIONS; RISK FACTORS; WORLD HEALTH;

EID: 38949101429     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2007.10.015     Document Type: Article

References (112)

1. Sasco AJ, Nikouline M. Flexible regression models for dynamic prediction of survival in elderly in presence of cancer or other chronic diseases. Adv Gerontol 2007; in press.
2. Huff J. Chemicals causally associated with cancers in humans and in laboratory animals: a perfect concordance. In: Waalkes M.P., and Ward J.M. (Eds). Carcinogenesis (1994), Raven Press, New York 25-37
3. Rall D.P. Can laboratory animal carcinogenicity studies predict cancer in exposed children?. Environ Health Perspect 103 Suppl. 6 (1995) 173-175
4. Turusov V.S., Trukhanova L.S., Partenv Yu D., and Tomatis L. Occurrence of tumours in descendants of CBA male mice prenatally treated with diethylstilbestrol. Int J Cancer 50 (1992) 131-135
5. Ferguson J.H. Effect of stilbestrol (diethylstilbestrol) on pregnancy compared to the effect of a placebo. Am J Obstet Gynecol 65 (1953) 592-601
6. Herbst A.L., Ulfelder H., and Poskanzer D.C. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. New Engl J Med 284 (1971) 878-881
7. European Commission. Opinion of the scientific committee on veterinary measures relating to public health. Assessment of potential risks to human health from hormone residues in bovine meat and meat products (1999), European Commission, Brussels
8. Carson R. Silent spring (1962), Houghton Mifflin, Boston
9. Sasco A.J. Epidémiologie comparée des cancers: un concept nouveau, un potentiel d'avenir. Sci Vét Méd Comp 93 (1991) 3-11
10. Sasco A.J. Comparative epidemiology of cancer. Epidemiology 4 (1993) 484-485
11. Sasco AJ, Zaidan Dagli ML. A comparative study of human and canine lymphoma in Sao Paulo. The role of the environment. Inserm-Fapeps protocol 2006.
12. Gavazza A., Presciuttini S., Barale R., Lubas G., and Gugliucci B. Association between canine malignant lymphoma, living in industrial areas, and use of chemicals by dog owners. J Vet Intern Med 15 (2001) 190-195
13. Bukowski J.A., Wartenberg D., and Goldschmidt M. Environmental causes for sinonasal cancers in pet dogs, and their usefulness as sentinels of indoor cancer risk. J Toxicol Environ Health A 54 (1998) 579-591
14. MacVean D.W., Monlux A.W., Anderson Jr. P.S., Silberg S.L., and Roszel J.F. Frequency of canine and feline tumors in a defined population. Vet Pathol 15 (1978) 700-715
15. Enriquez B, Le Moal J, Sasco AJ. Inserm-InVS protocol 2007.
16. Leroi A.M., Koufopanou V., and Burt A. Cancer selection. Nat Rev Cancer 3 (2003) 226-231
17. Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer incidence in five continents, vols. I-VIII. IARC CancerBase No. 7; 2005.
18. Parkin D.M., Bray F., Ferlay J., and Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 94 (2001) 153-156
19. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
20. International Agency for Research on Cancer. Hepatitis viruses. IARC monographs on the evaluation of carcinogenic risk to humans vol. 59 (1994), IARCPress, Lyon
21. International Agency for Research on Cancer. Epstein-Barr virus. IARC monographs on the evaluation of carcinogenic risk to humans vol. 70 (1997), IARCPress, Lyon
22. International Agency for Research on Cancer. Human immunodeficiency viruses and human T-cell lymphotropic viruses. IARC monographs on the evaluation of carcinogenic risk to humans vol. 67 (1997), IARCPress, Lyon
23. International Agency for Research on Cancer. Human papilloma viruses. IARC monographs on the evaluation of carcinogenic risk to humans, vol. 90. Geneva: WHO Press; in press.
24. International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risk to humans vol. 61 (1994), IARCPress, Lyon
25. Sasco A.J. Migrations et cancers. Rev Méd Interne 10 (1989) 341-348
26. Sasco A.J. Cancer prevention: how much do we really know? All-Party Parliamentary Group on Cancer. Britain against cancer. Cancer plan 2: towards 2010. The future of cancer care in the UK 2003 (2003), Church House, Westminster, London
27. Parkin D.M., Läärä E., and Muir C.S. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41 (1988) 184-197
28. Parkin D.M., Pisani P., and Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54 (1993) 594-606
29. Parkin D.M., Pisani P., and Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80 (1999) 827-841
30. Parkin D.M. Global cancer statistics in the year 2000. Lancet Oncol 2 (2001) 533-543
31. Belpomme D., Irigaray P., Sasco A.J., Newby J.A., Howard V., Clapp R., et al. The growing incidence of cancer: role of lifestyle and screening detection. Int J Oncol 30 (2007) 1037-1049
32. Webb P., Bain C., and Pirozzo S. Essential epidemiology: an introduction for students and health professionals (2005), Cambridge University Press, Cambridge
33. Wynder E.L., and Graham E.A. Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of 684 proved cases. J Am Med Assoc 143 4 (1950) 329-336
34. Lane-Claypon JE. A further report on cancer of the breast. Reports on public health and medical subjects, No 32. London: His Majesty's Stationary Office; 1926.
35. Hill A.B. The environment and disease: association or causation?. Proc R Soc Med 58 (1965) 295-300
36. Sasco A.J. Epidémiologie et prévention des cancers: quelques réflexions sur l'éthique des démarches de santé publique. Bull Acad Natle Méd 179 (1995) 987-1007
37. Easton D.F., Narod S.A., Ford D., and Steel M. The genetic epidemiology of BRCA1. Breast Cancer Linkage Consortium. Lancet 344 (1994) 761
38. Wooster R., Bignell G., Lancaster J., Swift S., Seal S., Mangion J., et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 378 (1995) 789-792
39. Lichtenstein P., Holm N.V., Verkasalo P.K., Iliadou A., Kaprio J., Koskenvuo M., et al. Environmental and heritable factors in the causation of cancer. N Engl J Med 343 (2000) 78-86
40. Czene K., Lichtenstein P., and Hemminki K. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish family-cancer database. Int J Cancer 99 (2002) 260-266
41. Schwartz L., Balasso J., Baillet F., Brun B., Amman J.P., and Sasco A.J. Cancer: the role of extra-cellular disease. Med Hypotheses 58 (2002) 340-346
42. Zeh III H.J., and Lotze M.T. Addicted to death: invasive cancer and the immune response to unscheduled cell death. J Immunother 28 (2005) 1-9
43. Sonnenschein C., and Soto A.M. The society of cells: cancer and control of cell proliferation (1999), BIOS Scientific Publishers, Oxford
44. Richter C.A., Birnbaum L.S., Farabollini F., Newbold R.R., Rubin B.S., Talsness C.E., et al. In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol 24 (2007) 199-224
45. Bay K., Asklund C., Skakkebaek N.E., and Andersson A.M. Testicular dysgenesis syndrome: possible role of endocrine disrupters. Best Pract Res Clin Endocrinol Metab 20 (2006) 77-90
46. Waterland R., and Jirtle R. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 23 (2003) 5293-5300
47. Herman J., and Baylin S. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349 (2003) 2042-2054
48. Anway M.D., and Skinner M.K. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 308 (2005) 1466-1469
49. Anway M.D., Leathers C., and Skinner M.K. Endocrine disruptor vinclozolin induced epigenetic transgenerational adult onset disease. Endocrinology 147 (2006) 5515-5523
50. Chang H.S., Anway M.D., Rekow S.S., and Skinner M.K. Transgenerational epigenetic imprinting of the male germline by endocrine disruptor exposure during gonadal sex determination. Endocrinology 147 (2006) 5524-5539
51. Crews D., Gore A.C., Hsu T.S., Dangleben N.L., Spinetta M., Schallert T., et al. Transgenerational epigenetic imprints on mate preference. Proc Natl Acad Sci U S A 104 (2007) 5942-5946
52. Vom Saal F.S., Akingbemi B.T., Belcher S.M., Birnbaum L.S., Crain D.A., Eriksen M., et al. Bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol 24 (2007) 131-138
53. Mackay J., Eriksen M., and Shafey O. The tobacco atlas. 2nd ed. (2005), American Cancer Society, Atlanta
54. International Agency for Research on Cancer. Tobacco smoke and involuntary smoking. IARC monographs on the evaluation of carcinogenic risk to humans vol. 83 (2004), IARCPress, Lyon
55. Sasco A.J., Secretan M.B., and Straif K. Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer 45 Suppl. 2 (2004) S3-S9
56. Gram I.T., Braaten T., Terry P.D., Sasco A.J., Adami H.O., Lund E., et al. Breast cancer risk among women who start smoking as teenagers. Cancer Epidemiol Biomarkers Prev 14 (2005) 61-66
57. Miller M.D., Marty M.A., Broadwin R., Johnson K.C., Salmon A.G., Winder B., et al. The association between exposure to environmental tobacco smoke and breast cancer: a review by the California Environmental Protection Agency. Prev Med 44 2 (2007) 93-106
58. Prignot JJ, Sasco AJ, Poulet E, Gupta PC, Aditama TY. Various forms of tobacco use. Int J Tub Lung Dis; in press.
59. Sasco A.J., Merrill R.M., Dari I., Benhaïm-Luzon V., Carriot F., Cann C.I., et al. A case-control study of lung cancer in Casablanca, Morocco. Cancer Causes Control 13 (2002) 609-616
60. Voirin N., Berthiller J., Benhaïm-Luzon V., Boniol M., Straif K., Ben Ayoub W., et al. Risk of lung cancer and past use of cannabis in Tunisia. J Thor Oncol 1 (2006) 577-579
61. Sasco A. Chapter 10. Cannabis et risques somatiques. Cannabis, données essentielles. In: Costes J.M. (Ed). Risques, conséquences et effets liés aux usages du cannabis (2007), OFDT, Saint-Denis La Plaine 90-96
62. International Agency for Research on Cancer. Alcohol drinking. IARC monographs on the evaluation of carcinogenic risk to humans vol. 44 (1988), IARCPress, Lyon
63. Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., Bouvard V., et al. Carcinogenicity of alcoholic beverages. Lancet Oncol 8 (2007) 292-293
64. Key J., Hodgson S., Omar R.Z., Jensen T.K., Thompson S.G., and Boobis A.R. Meta-analysis of studies of alcohol and breast cancer with consideration of the methodological issues. Cancer Causes Control 17 (2006) 759-770
65. Tuyns A.J., and Sasco A.J. Incidence of tobacco and alcohol-related cancers in western Europe. Eur J Cancer Prev 6 (1997) 560-561
66. World Cancer Research fund/American Institute for Cancer Research. Second expert report (2007), American Institute for Cancer Research, Washington DC
67. Cho E., Chen W.Y., Hunter D.J., Stampfer M.J., Colditz G.A., Hankinson S.E., et al. Red meat intake and risk of breast cancer among premenopausal women. Arch Intern Med 166 (2006) 2253-2259
68. Sasco A.J., Besson H., and Little R.E. Dietary habits during childhood and adolescence and breast cancer risk. In: Bruni V., and Dei M. (Eds). Pediatric and adolescent gynecology (2003), CIC Edizioni Internazionali, Rome 178-185
69. International Agency for Research on Cancer. Weight control and physical activity. IARC handbook on cancer prevention vol. 6 (2002), IARC Press, Lyon
70. Ibarluzea J.M., Fernández M.F., Santa-Marina L., Olea-Serrano M.F., Rivas A.M., Aurrekoetxea K., et al. Breast cancer risk and the combined effect of environmental estrogens. Cancer Causes Control 15 (2004) 591-600
71. International Agency for Research on Cancer. Solar and ultraviolet radiations. IARC monographs on the evaluation of carcinogenic risk to humans vol. 55 (1992), IARCPress, Lyon
72. Sasco A.J., Kaaks R., and Little R.E. Breast cancer: occurrence, risk factors and hormone metabolism. Expert Rev Anticancer Ther 3 (2003) 546-562
73. Cogliano V., Grosse Y., Baan R., Straif K., Secretan B., and El Ghissassi F. Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment. Lancet Oncol 6 (2005) 552-553
74. Sasco A.J. L'incidence et l'histoire naturelle des cancers du sein sont-elles modifiées par les traitements hormonaux au cours de la vie?. Oncologie 4 (2002) 2-4
75. International Agency for Research on Cancer. Attributable causes of cancer in France in the year 2000. IARC working group reports vol. 3 (2007), WHO Press, Geneva
76. Davis D.L., Axelrod D., Bailey L., Gaynor M., and Sasco A.J. Rethinking breast cancer risk and the environment: the case for the precautionary principle. Environ Health Persp 106 (1998) 523-529
77. Doll R., and Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 66 (1981) 1191-1308
78. Hardell L., Walker M.J., Walhjalt B., Friedman L.S., and Richter E.D. Secret ties to industry and conflicting interests in cancer research. Am J Ind Med 50 (2007) 227-240
79. Cogliano V. The science and practice of carcinogen identification and evaluation. Environ Health Perspect 112 (2004) 1269-1274
80. Belpomme D., Irigaray P., Hardell L., Clapp R., Montagnier L., Epstein S., et al. The multitude and diversity of environmental carcinogens. Environ Res 105 (2007) 414-429
81. Albanes D., Heinonen O.P., Taylor P.R., Virtamo J., Edwards B.K., Rautalahti M., et al. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 88 21 (1996) 1560-1570
82. Sasco A.J., Besson H., and Bianchini F. Où en est-on en chimioprévention?. Oncologie 4 (2002) 488-492
83. Cuzick J., and Baum M. Tamoxifen and contralateral breast cancer. Lancet 2 (1985) 282
84. Sasco A.J. Tamoxifen: a carcinogen as a preventive agent?. Cancer J 4 (1991) 217-218
85. Saez S., and Sasco A.J. Difficultés de la transposition en thérapeutique des activités biologiques analysées in vitro. L'exemple du tamoxifène. In: Martin P.M. (Ed). Cancer du sein: 20 ans de progrès. Tome 1: Biologie du cancer du sein: progrès récents (1994), Publications Médicales Internationales, Neuilly-sur-Seine 177-180
86. Sasco A.J., and Gendre I. Chapter 4: Carcinogenicity of tamoxifen. In: Kellen J.A. (Ed). Tamoxifen: beyond the antiestrogen (1996), Birkhaüser Boston Inc, Boston 59-92
87. Sasco A.J., Chaplain G., Amoros E., and Saez S. Endometrial cancer following breast cancer: effect of tamoxifen and castration by radiotherapy. Epidemiology 7 (1996) 9-13
88. Sasco A.J. Tamoxifen and menopausal status: risks and benefits. Lancet 34 (1996) 761
89. International Agency for Research on Cancer. Pharmaceutical drugs. IARC monographs on the evaluation of carcinogenic risk to humans vol. 50 (1996), IARCPress, Lyon
90. Eisinger F., Espié M., Kuttenn F., Lasset C., de Lignières B., Namer M., et al. La chimioprévention du cancer du sein. Prise de position au 3 juillet 1998 de la Fédération nationale des centres de lutte contre le cancer (FNCLCC). Bull Cancer 85 (1998) 725
91. Sasco A.J. Pharmacoprévention du cancer du sein par tamoxifène: devons-nous encore nous poser la question?. Rev Epidémiol Santé Publique 47 (1999) 279-285
92. Laurance J. Common form of the disease in Europe. Sharp rise in cases is blamed on increased prosperity, delayed childbirth and reduced breast-feeding. Independent 11 February 2007.
93. Montesano R. Hepatitis B immunization and hepatocellular carcinoma: The Gambia Hepatitis Intervention Study. J Med Virol 67 (2002) 444-446
94. The FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. New Engl J Med 356 (2007) 1915-1927
95. Markowitz L.E., Dunne E.F., Saraiya M., Lawson H.W., Chesson H., and Unger E.R. Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 56 RR-2 (2007) 1-24
96. Ministère de la Santé et des Solidarites. Avis du comité technique des vaccinations et du conseil supérieur d'hygiène publique de France section des maladies transmissibles relatif à la vaccination contre les papillomavirus humains 6, 11, 16 et 18. Direction générale de la santé (2007), République française, Paris
97. Sanders G.D., and Taira A.V. Cost-effectiveness of a potential vaccine for human papillomavirus. Emerg Infect Dis 9 (2003) 37-48
98. Bonnez W. Human papillomavirus vaccine: recent results and future developments. Curr Opin Pharmaco 7 (2007) 1-8
99. Sanofi Pasteur MSD. Merck fait don de trois millions de doses de son vaccin Gardasil® contre le cancer du col de l'utérus pour soutenir les programmes de vaccination des pays à faible revenu. Press communicate 27 (September 2007)
100. Sasco A.J. Tobacco and cancer: how to react to the evidence. Eur J Cancer Prev 1 (1992) 367-373
101. Sasco A.J., and Kleihues P. Why can't we convince the young not to smoke?. Eur J Cancer 35 (1999) 1933-1940
102. In: Greaves I., Jakegaonkar N., and Sanchez S. (Eds). Turning a leaf: women, tobacco, and the future (2006), British Columbia Centre of Excellence for Women's Health, Vancouver
103. Garcia-Giannoli H., and Sasco A.J. Prévention des cancers par les médecins généralistes du Rhône: une enquête déclarative. Bull Cancer 83 (1996) 853-863
104. Garrigues-Naserzadeh N., Sasco A.J., Lang F., and Vergnon J.M. Le médecin généraliste face à un patient fumeur. Rev Prat Méd Gén 16 (2002) 600-604
105. Sasco A.J. Législations antitabagiques en Europe: situation et évaluation d'impact. L'exemple de la France. Concours Méd 118 (1996) 1769-1773
106. Sasco A.J. Prévenir le tabagisme féminin, rôle de la législation, éducation pour une vie sans tabac. Méd Féminin 3 (2001) 19-21
107. An Expert Group. Research in the behavioural and social sciences to improve cancer control and care: a strategy for development. (No authors listed, but they included Sasco AJ as rapporteur and member of the planning group). Eur J Cancer 40 (2004) 316-325
108. Soffritti M., Belpoggi F., Minardi F., and Maltoni C. Ramazzini foundation cancer program: history and major projects, life-span carcinogenicity bioassay design, chemicals studied, and results. Ann NY Acad Sci 982 (2002) 26-45
109. Donovan M., Tiwary C.M., Axelrod D., Sasco A.J., Jones L., Hajek R., et al. Personal care products that contain estrogens or xenoestrogens may increase breast cancer risk. Med Hypotheses 68 (2006) 756-766
110. Hippocrates. On airs, waters, and places; 400 BC. Translated by Francis Adams [available from http://classics.mit.edu].
111. Snow J. On the mode of communication of cholera. 2nd ed. (1855), Churchill, London
112. Jen S., and Cobbing M. In: Cobbing M. (Ed). Navigating REACH (2007), Chemical Reaction, Brussels 48. accessed Sep 2007, available from http://www.chemicalreaction.org